$INCY· SEC filing ·

INCY Reports $1.27B Revenue, $1.10B Net Sales, +21% YoY, $758M Jakafi, $143M Opzelura, 10 Phase 3 Studies, $4.0B Cash

Incyte Genomics Inc · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $95.59

+1.4% in 1d after detection

Post-detection moves

1h
1d
+1.4%
3d
-0.8%
7d
+0.0%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS